BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 4919024)

  • 21. Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A.
    Muldoon RL; Stanley ED; Jackson GG
    Am Rev Respir Dis; 1976 Apr; 113(4):487-91. PubMed ID: 1267254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on induced influenza in man. II. Double-blind study designed to assess the prophylactic efficacy of an analogue of amantadine hydrochloride.
    Dawkins AT; Gallager LR; Togo Y; Hornick RB; Harris BA
    JAMA; 1968 Mar; 203(13):1095-9. PubMed ID: 4870515
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of nosocomial influenza infection with Amantadine.
    O'Donoghue JM; Ray CG; Terry DW; Beaty HN
    Am J Epidemiol; 1973 Apr; 97(4):276-82. PubMed ID: 4697648
    [No Abstract]   [Full Text] [Related]  

  • 24. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses.
    Sugiura A; Yanagawa H; Enomoto C; Ueda M; Tobita K
    J Infect Dis; 1970 Dec; 122(6):472-8. PubMed ID: 5496135
    [No Abstract]   [Full Text] [Related]  

  • 25. The therapeutic effect of amantadine in influenza occurring during the winter of 1971-2 assessed by double-blind study.
    Galbraith AW; Schild GC; Potter CW; Watson GI
    J R Coll Gen Pract; 1973 Jan; 23(126):34-7. PubMed ID: 4574716
    [No Abstract]   [Full Text] [Related]  

  • 26. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
    Dolin R; Reichman RC; Madore HP; Maynard R; Linton PN; Webber-Jones J
    N Engl J Med; 1982 Sep; 307(10):580-4. PubMed ID: 7050702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The prevention of A2-influenza in children by chemoprophylaxis with amantadine hydrochloride].
    Quilligan JJ; Hirayama M; Baernstein HD
    Schweiz Med Wochenschr; 1966 Dec; 96(50):1689-92. PubMed ID: 5340008
    [No Abstract]   [Full Text] [Related]  

  • 28. A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness.
    Finklea JF; Hennessy AV; Davenport FM
    Am J Epidemiol; 1967 May; 85(3):403-12. PubMed ID: 5337715
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.
    Quarles JM; Couch RB; Cate TR; Goswick CB
    Antiviral Res; 1981 Sep; 1(3):149-55. PubMed ID: 7337431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The suppression of A2 influenza in children by the chemoprophylactic use of Amantadine.
    Quilligan JJ; Hirayama M; Baernstein HD
    J Pediatr; 1966 Oct; 69(4):572-5. PubMed ID: 5950787
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A.
    Cohen A; Togo Y; Khakoo R; Waldman R; Sigel M
    J Infect Dis; 1976 Jun; 133 Suppl():A114-120. PubMed ID: 778307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Viregyt (amantadine hydrochloride) in the treatment of epidemic influenza.
    Máté J; Simon M; Juvancz I
    Ther Hung; 1971; 19(3):117-21. PubMed ID: 4946391
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of therapeutic efficacy of amantadine in patients with naturally occurring A2 influenza.
    Togo Y; Hornick RB; Felitti VJ; Kaufman ML; Dawkins AT; Kilpe VE; Claghorn JL
    JAMA; 1970 Feb; 211(7):1149-56. PubMed ID: 4904254
    [No Abstract]   [Full Text] [Related]  

  • 34. Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus.
    Sears SD; Clements ML
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1470-3. PubMed ID: 3435099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the antibody status of a population following epidemic infection by influenza virus A2-Hong Kong-1-68.
    Machin SJ; Potter CW; Oxford JS
    J Hyg (Lond); 1970 Sep; 68(3):497-504. PubMed ID: 5272348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trials of aqueous killed influenza vaccine in Canada, 1968-69.
    Williams MC; Davignon L; McDonald JC; Pavilanis PV; Boudreault A; Clayton AJ
    Bull World Health Organ; 1973; 49(4):333-40. PubMed ID: 4605401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A design for the evaluation of antiviral drugs in human influenza.
    Bloomfield SS; Gaffney TE; Schiff GM
    Am J Epidemiol; 1970 Jun; 91(6):568-74. PubMed ID: 4910877
    [No Abstract]   [Full Text] [Related]  

  • 38. [Epidemic of Hong-Kong A2 influenza in Yugoslavia].
    Vodopija I
    Lijec Vjesn; 1969; 91(12):1316-9. PubMed ID: 4913908
    [No Abstract]   [Full Text] [Related]  

  • 39. Amantadine hydrochloride as a prophylactic in respiratory infections. A double-blind investigation of its clinical use and serology.
    Callmander E; Hellgren L
    J Clin Pharmacol J New Drugs; 1968; 8(3):186-9. PubMed ID: 4872082
    [No Abstract]   [Full Text] [Related]  

  • 40. Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adults.
    Aoki FY; Stiver HG; Sitar DS; Boudreault A; Ogilvie RI
    Clin Pharmacol Ther; 1985 Feb; 37(2):128-36. PubMed ID: 3967455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.